Vanguard Group Inc Neogenomics Inc Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 13,903,735 shares of NEO stock, worth $144 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,903,735
Previous 14,130,761 1.61%
Holding current value
$144 Million
Previous $103 Million 3.91%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$4.84 - $8.81 $1.1 Million - $2 Million
-227,026 Reduced 1.61%
13,903,735 $107 Million
Q2 2025

Aug 11, 2025
SELL
$6.4 - $10.27 $808,672 - $1.3 Million
-126,355 Reduced 0.89%
14,130,761 $103 Million
Q1 2025

May 09, 2025
BUY
$9.09 - $18.61 $156,611 - $320,631
17,229 Added 0.12%
14,257,116 $135 Million
Q4 2024

Feb 11, 2025
BUY
$13.0 - $18.43 $2.55 Million - $3.61 Million
195,793 Added 1.39%
14,239,887 $235 Million
Q3 2024

Nov 13, 2024
SELL
$13.4 - $17.73 $1.04 Million - $1.37 Million
-77,396 Reduced 0.55%
14,044,094 $207 Million
Q2 2024

Aug 13, 2024
SELL
$13.01 - $15.77 $1.16 Million - $1.41 Million
-89,529 Reduced 0.63%
14,121,490 $196 Million
Q1 2024

May 10, 2024
BUY
$14.06 - $16.79 $581,437 - $694,333
41,354 Added 0.29%
14,211,019 $223 Million
Q4 2023

Feb 14, 2024
SELL
$11.67 - $20.73 $1.71 Million - $3.04 Million
-146,536 Reduced 1.02%
14,169,665 $229 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $3.94 Million - $5.79 Million
-324,613 Reduced 2.22%
14,316,201 $176 Million
Q2 2023

Aug 14, 2023
BUY
$14.1 - $19.83 $10.9 Million - $15.3 Million
770,257 Added 5.55%
14,640,814 $235 Million
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $1.78 Million - $3.81 Million
195,812 Added 1.43%
13,870,557 $241 Million
Q4 2022

Feb 10, 2023
BUY
$6.45 - $12.07 $3.23 Million - $6.04 Million
500,037 Added 3.8%
13,674,745 $126 Million
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $1.11 Million - $1.83 Million
-141,693 Reduced 1.06%
13,174,708 $113 Million
Q2 2022

Aug 12, 2022
BUY
$7.06 - $13.97 $2.44 Million - $4.83 Million
345,898 Added 2.67%
13,316,401 $109 Million
Q1 2022

May 13, 2022
BUY
$12.15 - $35.28 $1.38 Million - $4.01 Million
113,534 Added 0.88%
12,970,503 $158 Million
Q4 2021

Feb 14, 2022
BUY
$30.49 - $48.49 $5.69 Million - $9.05 Million
186,607 Added 1.47%
12,856,969 $439 Million
Q3 2021

Nov 12, 2021
BUY
$41.66 - $52.52 $19.7 Million - $24.8 Million
472,802 Added 3.88%
12,670,362 $611 Million
Q2 2021

Aug 13, 2021
BUY
$36.62 - $51.69 $447 Million - $630 Million
12,197,560 New
12,197,560 $551 Million

Others Institutions Holding NEO

# of Institutions
292
Shares Held
132M
Call Options Held
1.3M
Put Options Held
395K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.3B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email